IS THE CHOP REGIMEN A GOOD TREATMENT FOR ADVANCED CLL - RESULTS FROM 2 RANDOMIZED CLINICAL-TRIALS

被引:0
|
作者
FENAUX, P [1 ]
MOREL, P [1 ]
BAUTERS, F [1 ]
PIGUET, H [1 ]
MONCONDUIT, M [1 ]
TILLY, F [1 ]
DESABLENS, B [1 ]
CLAISSE, JF [1 ]
ADJIZIAN, JC [1 ]
POTRON, G [1 ]
PIGNON, B [1 ]
LEPORRIER, M [1 ]
TROUSSARD, X [1 ]
REMAN, O [1 ]
BINET, JL [1 ]
DIGHIERO, G [1 ]
MALOUM, K [1 ]
MERLEBERAL, H [1 ]
RAPHAEL, M [1 ]
REISENLEITER, M [1 ]
LINASSIER, C [1 ]
LAMAGNERE, JP [1 ]
JAUBERT, J [1 ]
VASSELOM, C [1 ]
LEBLAY, R [1 ]
JACOMY, D [1 ]
GROSBOIS, B [1 ]
DREYFUS, B [1 ]
GUILHOT, F [1 ]
VAUGIER, G [1 ]
SOUTEYRAND, P [1 ]
LEPEU, G [1 ]
TOUCHAIS, AM [1 ]
BOUDJERRA, N [1 ]
BORDESSOULE, M [1 ]
SCHMIDT, J [1 ]
FACQUETDANIS, J [1 ]
SEBBAN, C [1 ]
ALLARD, C [1 ]
MURGUE, B [1 ]
SCHVED, JF [1 ]
ARNAUD, A [1 ]
CASSASSUS, P [1 ]
LEPRISE, PY [1 ]
DOR, JF [1 ]
TURPIN, F [1 ]
SOLALCELIGNY, P [1 ]
TERTIAN, G [1 ]
BERNARD, JF [1 ]
JAMES, JM [1 ]
机构
[1] CTR HOSP REG & UNIV LILLE,F-59037 LILLE,FRANCE
关键词
CHOP REGIMEN; TREATMENT; ADVANCED CLL; LYMPHOCYTIC LEUKEMIA; RANDOMIZED CLINICAL TRIALS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Between 1985 and 1990, the French Cooperative Group on Chronic Lymphocytic Leukemia (CLL) randomized 287 stage B patients between intermittent chlorambucil plus prednisone (n=140) or CHOP (n=147), and 90 stage C patients between CHOP (n=44) or CHOP plus methotrexate (n=46). In stage B, although treatment response was improved with CHOP (p=0.007, chi-square test), no difference in survival was observed between the two randomized groups (p=0.33, score test). In stage C, no differences in treatment response and survival were shown, with median survival close to that reported with CHOP in the previous CLL-80 trial. These results associated with those from other groups raise the question whether the CHOP regimen, which has been consistently shown to improve response to therapy, is an effective treatment in advanced CLL patients.
引用
收藏
页码:449 / 456
页数:8
相关论文
共 30 条
  • [1] QUALITY ASSESSMENT OF RANDOMIZED CLINICAL-TRIALS ON MEDICAL-TREATMENT OF DIABETIC NEUROPATHY
    CAVALIERE, D
    SCORPIGLIONE, N
    BELFIGLIO, M
    CARINCI, F
    CUBASSO, D
    LABBROZZI, D
    MARI, E
    BENEDETTI, MM
    PONTANO, C
    TOGNONI, G
    NICOLUCCI, A
    DIABETES NUTRITION & METABOLISM, 1994, 7 (05) : 287 - 294
  • [2] CRITICAL-REVIEW OF THE QUALITY AND DEVELOPMENT OF RANDOMIZED CLINICAL-TRIALS (RCTS) AND THEIR INFLUENCE ON THE TREATMENT OF ADVANCED EPITHELIAL OVARIAN-CANCER
    MARSONI, S
    TORRI, W
    TAIANA, A
    GAMBINO, A
    GRILLI, R
    LIATI, P
    FRANZOSI, MG
    PISTOTTI, V
    PARAZZINI, F
    FOCARILE, F
    LIBERATI, A
    ANNALS OF ONCOLOGY, 1990, 1 (05) : 343 - 350
  • [3] ADJUVANT CHEMOTHERAPY FOR SOFT-TISSUE SARCOMA - REVIEW AND METAANALYSIS OF THE PUBLISHED RESULTS OF RANDOMIZED CLINICAL-TRIALS
    TIERNEY, JF
    MOSSERI, V
    STEWART, LA
    SOUHAMI, RL
    PARMAR, MKB
    BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 469 - 475
  • [4] AN EMPIRICAL-STUDY OF THE POSSIBLE RELATION OF TREATMENT DIFFERENCES TO QUALITY SCORES IN CONTROLLED RANDOMIZED CLINICAL-TRIALS
    EMERSON, JD
    BURDICK, E
    HOAGLIN, DC
    MOSTELLER, F
    CHALMERS, TC
    CONTROLLED CLINICAL TRIALS, 1990, 11 (05): : 339 - 352
  • [5] Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials
    Johansson, P. I.
    VOX SANGUINIS, 2008, 95 (01) : 1 - 7
  • [6] Is Anticonvulsant Treatment of Mania a Class Effect? Data from Randomized Clinical Trials
    Rosa, A. R.
    Fountoulakis, K.
    Siamouli, M.
    Gonda, X.
    Vieta, E.
    CNS NEUROSCIENCE & THERAPEUTICS, 2011, 17 (03) : 167 - 177
  • [7] Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer
    Fernandez-Lopez, Cristina
    Exposito-Hernandez, Jose
    Pedro Arrebola-Moreno, Juan
    Angel Calleja-Hernandez, Miguel
    Exposito-Ruiz, Manuela
    Guerrero-Tejada, Rosa
    Linares, Isabel
    Cabeza-Barrera, Jose
    CANCER MEDICINE, 2016, 5 (09): : 2190 - 2197
  • [8] Fidaxomicin for the Treatment of Clostridioides difficile Infection in Adult Patients: An Update on Results from Randomized Controlled Trials
    Giacobbe, Daniele Roberto
    Vena, Antonio
    Falcone, Marco
    Menichetti, Francesco
    Bassetti, Matteo
    ANTIBIOTICS-BASEL, 2022, 11 (10):
  • [9] Effect of individualized communication skills training on physicians' discussion of clinical trials in oncology: results from a randomized controlled trial
    Wuensch, Alexander
    Goelz, Tanja
    Ihorst, Gabriele
    Terris, Darcey D.
    Bertz, Hartmut
    Bengel, Juergen
    Wirsching, Michael
    Fritzsche, Kurt
    BMC CANCER, 2017, 17
  • [10] Effect of individualized communication skills training on physicians’ discussion of clinical trials in oncology: results from a randomized controlled trial
    Alexander Wuensch
    Tanja Goelz
    Gabriele Ihorst
    Darcey D. Terris
    Hartmut Bertz
    Juergen Bengel
    Michael Wirsching
    Kurt Fritzsche
    BMC Cancer, 17